Request a quote
Independent reading
Selected scientific papers and educational articles relating to compounds in the Biovyra catalogue. Inclusion is not an endorsement of any therapeutic or personal use.
Peer-reviewed Phase 2 clinical research describing retatrutide as a GIP, GLP-1 and glucagon receptor agonist. The authors state that further investigation was required.
The New England Journal of Medicine · Clinical researchFoundational preclinical research examining mitochondrial signalling and metabolic homeostasis in cells and animal models.
Cell Metabolism / PubMed Central · Preclinical researchA medically reviewed consumer overview focused mainly on topical GHK-Cu. It distinguishes topical evidence from the limited evidence and regulatory concerns around injectable use.
Midi Health · Medically reviewed educational articleA scientific review of copper binding, extracellular-matrix signalling and skin-remodelling pathways. Much of the evidence discussed is laboratory or topical research.
BioMed Research International · Scientific reviewA scientific overview of glutathione's roles in cellular redox balance, oxidative stress and protection from reactive compounds.
Molecular Aspects of Medicine / PubMed Central · Scientific reviewResearch stages differ by compound, formulation and route of administration. Preclinical, topical or early clinical findings do not establish safety or efficacy for general human use. Biovyra materials are currently supplied only to verified professional organisations for qualified laboratory research.